What is the dosage of fondaparinux for treatment of superficial thrombophlebitis?

Updated: Feb 25, 2021
  • Author: Khanjan H Nagarsheth, MD, MBA; Chief Editor: Vincent Lopez Rowe, MD  more...
  • Print

Use of the lowest dosage of fondaparinux (2.5 mg/day subcutaneously) for 45 days was shown by Decousus et al to suffice for prevention of extension, recurrence, and embolization of superficial venous thrombosis. [27] Another advantage to this anticoagulant medication is that the dosage studied for superficial venous thrombosis does not have to be monitored. At this dosage, fondaparinux has not been shown to affect activated partial thromboplastin time (aPTT), prothrombin time (PT), or bleeding time. [28]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!